SCHEMBL23101892

SCHEMBL23101892

C=C(Br)CCCC(=O)OC

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.68
LMNA P02545 4/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
GLA P06280 1/20 0.42
CA12 O43570 2/20 0.39
CA14 Q9ULX7 2/20 0.39
KDM4E B2RXH2 1/20 0.39
RECQL P46063 1/20 0.39
HSD17B10 Q99714 2/20 0.38
OXER1 Q8TDS5 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12394196 0.86
Ethylene SCHEMBL11220916 0.83 TSHR (0.88) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL50039 0.83 TSHR (1.00) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL28238018 0.83 TSHR (1.00) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL6629340 0.80 TSHR (0.94) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL8069375 0.80 TSHR (0.94) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL8584321 0.80 TSHR (0.94) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL7939557 0.80 TSHR (0.94) TSHRLMNAALDH1A1KMT2AMEN1
Dimethyl Succinate SCHEMBL7262656 0.80 TSHR (0.94) TSHRLMNAALDH1A1KMT2AMEN1
SCHEMBL8582764 0.80 TSHR (0.94) TSHRLMNAALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617749-B2 Cannabinoid derivatives and precursors, and asymmetric synthesis for same KARE CHEMICAL TECHNOLOGIES INC. (CA) 2026-05-05 US disclosed
US-20220340514-A1 CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME KARE CHEMICAL TECHNOLOGIES INC. (CA) 2022-10-27 US disclosed
WO-2021046640-A1 CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME KARE CHEMICAL TECHNOLOGIES INC. (CA) 2021-03-18 WO disclosed
WO-2021046640-A1 CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME KARE CHEMICAL TECHNOLOGIES INC. (CA) 2021-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220340514-A1 CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRIC SYNTHESIS FOR SAME CNR2, CNR1, CYP2A13 TSHR 3763/4885LMNA 3963/4885ALDH1A1 2689/4885
US-12617749-B2 Cannabinoid derivatives and precursors, and asymmetric synthesis for same CNR1, CNR2, OPRD1 TSHR 1324/4885LMNA 2720/4885ALDH1A1 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.